Edition:
India

Sumitomo Dainippon Pharma Co Ltd (4506.T)

4506.T on Tokyo Stock Exchange

1,925JPY
29 Mar 2017
Change (% chg)

-- (--)
Prev Close
¥1,925
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
1,116,291
52-wk High
¥2,134
52-wk Low
¥1,246

4506.T

Chart for 4506.T

About

Sumitomo Dainippon Pharma Co., Ltd., formerly Dainippon Sumitomo Pharma Co.,Ltd., is a pharmaceutical company. The Japan division manufactures and sells ethical and general use drugs. The North America division manufactures, develops, purchases and sells ethical drugs through its consolidated subsidiaries. The China division... (more)

Overall

Beta: 0.76
Market Cap(Mil.): ¥767,549.38
Shares Outstanding(Mil.): 397.90
Dividend: 9.00
Yield (%): 0.93

Financials

  4506.T Industry Sector
P/E (TTM): 24.78 29.38 30.19
EPS (TTM): 77.83 -- --
ROI: 5.67 13.66 13.17
ROE: 6.57 14.55 14.30

BRIEF-Sumitomo Dainippon Pharma looks to expand applications of drug candidate Dasotraline - Nikkei

* Sumitomo Dainippon Pharma Co Ltd looks to expand the applications of its drug candidate dasotraline - Nikkei

25 Mar 2017

BRIEF-Sumitomo Dainippon Pharma completes full acquisition of Cynapsus Therapeutics via unit

* Says its US-based unit completes full acquisition of 100 percent stake of shares and entire warrants in Cynapsus Therapeutics Inc, on Oct. 21 (U.S.A. Eastern Standard Time), at about $635 million

24 Oct 2016

BRIEF-Sumitomo Dainippon Pharma announces result of early-retirement program

* Says 295 employees took up the offer of the early-retirement program announced on Aug. 30

21 Oct 2016

BRIEF-Sumitomo Dainippon Pharma unit to buy 100 pct stake in Cynapsus Therapeutics Inc. at $624 mln

* Says its subsidiary will buy 100 percent stake in Cynapsus Therapeutics Inc. at $624 million by the end of Dec.

04 Oct 2016

More From Around the Web

Earnings vs. Estimates